Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden

Caitlin E. Cox

October 31, 2022

Presentation ESC 2022

Efficacy and Safety of the Oral Factor XIa Inhibitor, Asundexian, Added to Dual Antiplatelet Therapy After an Acute Myocardial Infarction

Presenter: John H. Alexander

August 28, 2022

News Conference News ESC 2022

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

Todd Neale

August 28, 2022

News Daily News

Longer-Term Data Still Worrisome for Impella-Treated AMICS Patients

Caitlin E. Cox

July 20, 2022

News Daily News

Respiratory Issues Dominate NACMI Risk Score for COVID/STEMI Mortality

L.A. McKeown

July 13, 2022

News Conference News EAS 2022

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Michael O'Riordan

May 26, 2022

News Daily News

Higher Single-Sample hs-cTnT Threshold Can Safely Exclude MI

Michael O'Riordan

May 13, 2022

News Daily News

Acute MI Workup in Emergency Departments Varies by Sex and Race

Michael O'Riordan

May 11, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

Michael O'Riordan

April 22, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

News Daily News

Type 2 MI Not Uncommon in the Emergency Department

Michael O'Riordan

March 16, 2022

News Daily News

GRACE Performs Poorly in Ethnic Minorities With NSTEMI, Study Finds

L.A. McKeown

March 01, 2022

News Daily News

Delayed Care for NSTEMI Linked to Higher Mortality Over 3 Years

Yael L. Maxwell

January 27, 2022

Advertisement

STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden

Efficacy and Safety of the Oral Factor XIa Inhibitor, Asundexian, Added to Dual Antiplatelet Therapy After an Acute Myocardial Infarction

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

Longer-Term Data Still Worrisome for Impella-Treated AMICS Patients

Respiratory Issues Dominate NACMI Risk Score for COVID/STEMI Mortality

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Higher Single-Sample hs-cTnT Threshold Can Safely Exclude MI

Acute MI Workup in Emergency Departments Varies by Sex and Race

Good News and Bad for High-Intensity Statin Use in ASCVD

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Type 2 MI Not Uncommon in the Emergency Department

GRACE Performs Poorly in Ethnic Minorities With NSTEMI, Study Finds

Delayed Care for NSTEMI Linked to Higher Mortality Over 3 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content